Boston Scientific CorporationBSXNYSE
Loading
ROE: Strong ReturnsExpanding
Percentile Rank86
3Y CAGR+44.2%
Year-over-Year Change
Return on equity
3Y CAGR
+44.2%/yr
vs -32.5%/yr prior
Acceleration
+76.7pp
Accelerating
Percentile
P86
Within normal range
vs 3Y Ago
3x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 11.91% | +39.8% |
| 2024 | 8.52% | +3.1% |
| 2023 | 8.26% | +108.0% |
| 2022 | 3.97% | -36.5% |
| 2021 | 6.26% | +1269.4% |
| 2020 | -0.54% | -101.6% |
| 2019 | 33.87% | +76.8% |
| 2018 | 19.15% | +1191.1% |
| 2017 | 1.48% | -71.2% |
| 2016 | 5.15% | - |